Bio-Techne Corp (TECH)

75.19 +0.42 (+0.56%) USD  |  NASDAQ  |  Jan 08, 16:00
75.98 +0.79 (+1.05%) Pre-Market: 08:58
More

Bio-Techne SG&A Expense (Quarterly): 119.16M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for TECH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Haemonetics Corp 106.95M
Boston Scientific Corp 1.562B
Bio-Rad Laboratories Inc 200.44M
ResMed Inc 238.98M
Zimmer Biomet Holdings Inc 709.70M